Clin2
NCT07539623Likely a fitRecruiting

Pain relief with suzetrigine after heart or weight-loss surgery

Bariatric SurgeryCardiac Surgery With SternotomyPost-operative Pain

Treatments studied

Part of Pain clinical trials.

This study tests whether suzetrigine, a new pain medication, can reduce the need for opioids (strong painkillers) after cardiac or bariatric surgery. The goal is to help patients manage pain with fewer opioid-related side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
235 people
Ages
18 years to 85 years
Study type
Interventional

Who can take part

  • You are between 18 and 85 years old
  • You are scheduled for heart surgery (sternotomy) or weight-loss surgery (laparoscopic or open)
  • You do not have a serious heart or medical condition classified as ASA Class V
  • Your surgery is planned in advance (not urgent or emergency)
  • You have no history of substance use disorder or long-term opioid use before surgery
  • You are not taking certain medications that interact with suzetrigine (your doctor will review your full medication list)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07548385Recruiting· Phase 3
New pain medicine for after knee replacement surgery

This study tests a new medication called suzetrigine to help manage pain after knee replacement surgery. The goal is to see if it reduces pain and discomfort better than current treatments.

New York, New York
NCT07226700Recruiting· Phase 3
Suzetrigine for pain after hip replacement surgery

This study tests an investigational pain medicine called suzetrigine to see how well it controls pain after total hip replacement surgery. It is for adults 18–80 who are having a first-time hip replacement and can receive spinal anesthesia.

New York, New York
NCT07624526Not yet recruiting· Phase 4
Suzetrigine to Reduce Pain and Opioid Use After Knee Surgery

This study tests whether a new pain medication called suzetrigine, when combined with other pain-management strategies, can reduce pain and the need for opioids after total knee replacement surgery. The goal is to help patients recover comfortably while using fewer opioids.

Atlanta, Georgia
NCT07463430Enrolling by invitation· Phase 4
Suzetrigine for pain after non-mastectomy breast surgery

This trial tests a new pain medication, suzetrigine, for people having breast surgery (not mastectomy) who are expected to have moderate pain. It checks if this drug works well compared to standard options.

San Diego, California
NCT07672015Recruiting· Phase 4
Testing a new pain drug in surgery patients at risk for opioid dependence

This trial tests a new painkiller called suzetrigine for post-surgery pain. It's designed for people whose medical records suggest they may have a higher chance of needing strong painkillers (opioids) long after surgery. We want to see if suzetrigine works better at preventing that.

La Jolla, California
NCT07357376Not yet recruiting· Phase 3
Study of suzetrigine for pain after knee replacement surgery

This study tests a new pain medicine called suzetrigine for people having a first-time total knee replacement. The goal is to see if it helps control pain after surgery.

Hear when a new Bariatric Surgery trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.